World (JR) – As marijuana use becomes ever more socially and legally acceptable in the developed world, researchers are scrambling to understand how the plant — more potent today than ever before — impacts our health. Marijuana is now legal in 28 U.S. states for…
A team of scientists in Dublin has found that a particular region of the brain reacts differently to stimuli in those with autism spectrum disorders (ASD). The team believe that their findings could be useful in devising new therapies for those afflicted with ASD.
The research team, led by Dr. Joshua Henk Balsters, a neurologist with ETH Zürich, sought to discover more effective treatments for autism, according to Independent.ie, as, “whenever we have spoken with parents of children with autism, interaction is something that parents find very sad or very difficult.”
Balsters’ team, composed of scientists from Ireland, Switzerland, and the UK, performed MRI scans on the brains of people with ASD, and on control subjects with no neural disorders. Balsters found a difference in activity between the two groups in a specific part of the brain.
The rise in recent decades of diseases such as inflammatory bowel disease and rheumatoid arthritis suggests that factors in the environment are contributing.
In 1932, New York gastroenterologist Burrill Crohn described an unusual disease in 14 adults. The patients had bouts of abdominal pain, bloody diarrhea, and lesions and scars on the bowel wall. Doctors in other parts of North America and Europe were seeing it in their patients, too. They called the rare condition Crohn’s disease. After World War II, the number of new people getting inflammatory bowel disease (Crohn’s disease and a related condition called ulcerative colitis) skyrocketed across the West in countries such as the U.S., Canada and the UK. In the last three decades, IBD has begun to crop up in newly industrialized parts of the world like Hong Kong and China’s big cities.
The Zika virus’ spread has catalyzed a massive industry boom for big-biotechnology. It’s an industry making bank off manufacturing poison, and even mutants. Interestingly, it’s latest mosquitocide comes along with a study guaranteeing it’s eco-friendly.
“We’re essentially preventing mosquitoes from producing urine”, says Vanderbilt pharmacologist Jerod Denton, Ph.D. According to Science Daily, the pesticide–VU041–was developed to transcend the insect’s adaptive prowess. Denton joined colleagues in an evaluation of its possible ecological impacts.
Your body has one more organ than previously thought, according to new research from Ireland’s University Hospital Limerick. The new organ is called the mesentery, an object that was formerly believed to be several tissue structures. Researchers have called this a major breakthrough in the fields of abdominal and digestive diseases.
A new paper published in the Lancet Gastroenterology & Hepatology has reclassified the mesentery, formerly thought to be a fragmented membrane, as an organ, following microscopic research that revealed it to be one continuous structure. The mesentery is a double fold of peritoneum (the membrane that forms the lining of the abdomen) that attaches the gastrointestinal tract to the walls of the abdomen. Nerves and blood vessels are sandwiched in the fold.
Psychedelic science continues it’s redemptive march out of obscurity, and stigma. Decades of misinformation and propaganda is crumbling in a free fall accelerated by cannabis reforms. It’s a revolution conjuring up uses for psychedelics ignored since the days of 1960’s counter-culture. Among those benefits, researchers now say, is an uncanny ability to remedy the chains addiction.
The findings hail from a study done by numerous United Kingdom-based researchers. Unlike many, the study noted the “thousands of years” of historical use of psychedelics by indigenous cultures. It’s a facet sometimes referenced, but rarely held with any real credibility, or esteem. Rather, such native knowledge is left to languish well beyond the margins of academia. The UK study also acknowledged the role legislation has played in stunting psychedelic inquiry.
A group of Russian scientists obtained a new anticancerous compound that has the ability to combat cancer cells even if they are resistant to chemotherapy.
Moscow Institute of Physics and Technology (MIPT) Professor Alexander Kiselyov who leads the research told Sputnik International about the novel substance.
“The chemical compound was synthesized from an early product found in nature — parsley and dill seeds. Liquid carbon dioxide was used for extracting the needed natural components, which were then purified in the N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences,” explained Prof. Kiselyov, Moscow State University graduate, who received PhD degree in synthetic organic chemistry at the Georgia State University, was a Postdoc fellow at the Ben May Department for Cancer Research of the University of Chicago and at the Columbia University and now continues to work in national medicinal chemistry, structural biology and drug development.
Pharmaceutical giants have never shied away from the chance to make large profits from the sale of their medicines. But what if there was a way to marry corporate and social goals – to delight shareholders and tackle the most pressing global public health epidemics?
An initiative called the Health Impact Fund (HIF) has its eyes set on making medicines affordable and available to all. Supported by leading health scientists, Nobel-prize winning researchers and even former Canadian prime minister Paul Martin, it proposes a system that incentivizes pharmaceutical companies to research and develop drugs for neglected diseases and provides financial rewards to those that significantly reduce the global burden of disease.